Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$962M |
| 2 |
AbbVie
ABBV
|
+$512M |
| 3 |
Bank of America
BAC
|
+$172M |
| 4 |
TJX Companies
TJX
|
+$157M |
| 5 |
GE Vernova
GEV
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$636M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$388M |
| 3 |
Palantir
PLTR
|
+$253M |
| 4 |
Applovin
APP
|
+$236M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.84% |
| 2 | Technology | 16.54% |
| 3 | Financials | 9.27% |
| 4 | Industrials | 6.9% |
| 5 | Healthcare | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3401
Constellium
CSTM
$3.32B
| $1.29M | ﹤0.01% |
96,957
+50,592
| +109% | +$568K |
2024 Q4
2 quarters
|
|
|
APLS
3402
DELISTED
Apellis Pharmaceuticals
APLS
| $1.29M | ﹤0.01% |
74,466
+22,488
| +43% | +$416K |
2024 Q4
2 quarters
|
|
3403
Eton Pharmaceutcials
ETON
$1.56B
| $1.29M | ﹤0.01% |
90,415
+12,202
| +16% | +$193K |
2024 Q4
2 quarters
|
|
3404
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$333M
| $1.29M | ﹤0.01% |
10,314
+1,490
| +17% | +$173K |
2024 Q4
2 quarters
|
|
3405
Cheesecake Factory
CAKE
$5.4B
| $1.29M | ﹤0.01% |
20,520
-6,404
| -24% | -$341K |
2024 Q4
2 quarters
|
|
3406
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$282M
| $1.28M | ﹤0.01% |
22,750
-7,335
| -24% | -$375K |
2024 Q4
2 quarters
|
|
3407
Lands' End
LE
$309M
| $1.28M | ﹤0.01% |
119,922
+16,052
| +15% | +$145K |
2024 Q4
2 quarters
|
|
3408
Electromed
ELMD
$233M
| $1.28M | ﹤0.01% |
58,331
+1,053
| +2% | +$22.9K |
2024 Q4
2 quarters
|
|
3409
Phibro Animal Health
PAHC
$1.51B
| $1.28M | ﹤0.01% |
50,150
-2,197
| -4% | -$47.9K |
2024 Q4
2 quarters
|
|
3410
iShares Bloomberg Roll Select Commodity Strategy ETF
CMDY
$701M
| $1.28M | ﹤0.01% |
25,392
+1,029
| +4% | +$51.7K |
2024 Q4
2 quarters
|
|
3411
LendingTree
TREE
$347M
| $1.28M | ﹤0.01% |
34,540
+2,035
| +6% | +$82.2K |
2024 Q4
2 quarters
|
|
3412
Innovator S&P Investment Grade Preferred ETF
EPRF
$64.2M
| $1.28M | ﹤0.01% |
72,435
+2,553
| +4% | +$44.6K |
2024 Q4
2 quarters
|
|
|
PML
3413
PIMCO Municipal Income Fund II
PML
$434M
| $1.28M | ﹤0.01% |
171,388
-207,605
| -55% | -$1.57M |
2024 Q4
2 quarters
|
|
|
MCI
3414
Barings Corporate Investors
MCI
$367M
| $1.27M | ﹤0.01% |
58,794
+8,252
| +16% | +$169K |
2024 Q4
2 quarters
|
|
3415
Box
BOX
$4.73B
| $1.27M | ﹤0.01% |
37,237
+541
| +1% | +$17.7K |
2024 Q4
2 quarters
|
|
3416
Costamare
CMRE
$1.86B
| $1.27M | ﹤0.01% |
139,584
+26,585
| +24% | +$237K |
2024 Q4
2 quarters
|
|
3417
Avista
AVA
$2.95B
| $1.27M | ﹤0.01% |
33,501
+23,909
| +249% | +$943K |
2024 Q4
2 quarters
|
|
|
EXK
3418
Endeavour Silver
EXK
$2.53B
| $1.26M | ﹤0.01% |
257,089
+102,389
| +66% | +$403K |
2024 Q4
2 quarters
|
|
3419
News Corp Class A
NWSA
$15.5B
| $1.26M | ﹤0.01% |
42,528
+1,439
| +4% | +$39.6K |
2024 Q4
2 quarters
|
|
3420
Innovator Equity Defined Protection ETF - 2 Yr to April 2028
AAPR
$70.9M
| $1.26M | ﹤0.01% |
46,259
+3,985
| +9% | +$105K |
2024 Q4
2 quarters
|
|
3421
PagerDuty
PD
$1.2B
| $1.26M | ﹤0.01% |
82,537
-10,068
| -11% | -$156K |
2024 Q4
2 quarters
|
|
3422
Global X Autonomous & Electric Vehicles ETF
DRIV
$361M
| $1.26M | ﹤0.01% |
54,028
-11,286
| -17% | -$242K |
2024 Q4
2 quarters
|
|
3423
CALL
Viper Energy
VNOM
$7.92B
| $1.26M | ﹤0.01% |
35,900
-2,300
| -6% | -$93K |
2025 Q1
1 quarter
|
|
3424
FS Bancorp
FSBW
$350M
| $1.25M | ﹤0.01% |
31,846
-3,968
| -11% | -$154K |
2024 Q4
2 quarters
|
|
3425
BV Financial
BVFL
$179M
| $1.25M | ﹤0.01% |
+81,917
| New | +$1.23M |
2025 Q2
0 quarters
|
|
Similar funds
Raymond James Financial's Q2 2025 Portfolio in Review
As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Raymond James Financial's Q2 2025 filing shows 2,183 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 40% a quarter earlier, followed by Technology and Financials.
- Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
- Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
- Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
- Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
- Raymond James Financial opened 2,183 new positions and closed 80 in Q2 2025.
- Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.
Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.